Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy

The blood–retinal barrier (BRB) is strongly compromised in diabetic retinopathy (DR) due to the detachment of pericytes (PCs) from retinal microvessels, resulting in increased permeability and impairment of the BRB. Western blots, immunofluorescence and ELISA were performed on adipose mesenchymal st...

Full description

Bibliographic Details
Main Authors: Aleksandra Agafonova, Alessia Cosentino, Ivana Roberta Romano, Giovanni Giurdanella, Floriana D’Angeli, Rosario Giuffrida, Debora Lo Furno, Carmelina Daniela Anfuso, Giuliana Mannino, Gabriella Lupo
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/3/1774
_version_ 1797318703756345344
author Aleksandra Agafonova
Alessia Cosentino
Ivana Roberta Romano
Giovanni Giurdanella
Floriana D’Angeli
Rosario Giuffrida
Debora Lo Furno
Carmelina Daniela Anfuso
Giuliana Mannino
Gabriella Lupo
author_facet Aleksandra Agafonova
Alessia Cosentino
Ivana Roberta Romano
Giovanni Giurdanella
Floriana D’Angeli
Rosario Giuffrida
Debora Lo Furno
Carmelina Daniela Anfuso
Giuliana Mannino
Gabriella Lupo
author_sort Aleksandra Agafonova
collection DOAJ
description The blood–retinal barrier (BRB) is strongly compromised in diabetic retinopathy (DR) due to the detachment of pericytes (PCs) from retinal microvessels, resulting in increased permeability and impairment of the BRB. Western blots, immunofluorescence and ELISA were performed on adipose mesenchymal stem cells (ASCs) and pericyte-like (P)-ASCs by co-cultured human retinal endothelial cells (HRECs) under hyperglycemic conditions (HG), as a model of DR. Our results demonstrated that: (a) platelet-derived growth factor receptor (PDGFR) and its activated form were more highly expressed in monocultured P-ASCs than in ASCs, and this expression increased when co-cultured with HRECs under high glucose conditions (HG); (b) the transcription factor Nrf2 was more expressed in the cytoplasmic fraction of ASCs and in the P-ASC nuclear fraction, under normal glucose and, even more, under HG conditions; (c) cytosolic phospholipase A<sub>2</sub> activity and prostaglandin E2 release, stimulated by HG, were significantly reduced in P-ASCs co-cultured with HRECs; (d) HO-1 protein content was significantly higher in HG-P-ASCs/HRECs than P-ASCs/HRECs; and (e) VEGF-A levels in media from HG-co-cultures were reduced in P-ASCs/HRECs with respect to ASCs/HRECs. The data obtained highlighted the potential of autologous differentiated ASCs in future clinical applications based on cell therapy to counteract the damage induced by DR.
first_indexed 2024-03-08T03:55:08Z
format Article
id doaj.art-ea89af614c264a8389c6297de4e0475d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-08T03:55:08Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-ea89af614c264a8389c6297de4e0475d2024-02-09T15:14:34ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-02-01253177410.3390/ijms25031774Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic RetinopathyAleksandra Agafonova0Alessia Cosentino1Ivana Roberta Romano2Giovanni Giurdanella3Floriana D’Angeli4Rosario Giuffrida5Debora Lo Furno6Carmelina Daniela Anfuso7Giuliana Mannino8Gabriella Lupo9Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, ItalyFaculty of Medicine and Surgery, University of Enna “Kore”, 94100 Enna, ItalyDepartment of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, 00166 Rome, ItalyDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, ItalyDepartment of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, 98122 Messina, ItalyDepartment of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania, 95123 Catania, ItalyThe blood–retinal barrier (BRB) is strongly compromised in diabetic retinopathy (DR) due to the detachment of pericytes (PCs) from retinal microvessels, resulting in increased permeability and impairment of the BRB. Western blots, immunofluorescence and ELISA were performed on adipose mesenchymal stem cells (ASCs) and pericyte-like (P)-ASCs by co-cultured human retinal endothelial cells (HRECs) under hyperglycemic conditions (HG), as a model of DR. Our results demonstrated that: (a) platelet-derived growth factor receptor (PDGFR) and its activated form were more highly expressed in monocultured P-ASCs than in ASCs, and this expression increased when co-cultured with HRECs under high glucose conditions (HG); (b) the transcription factor Nrf2 was more expressed in the cytoplasmic fraction of ASCs and in the P-ASC nuclear fraction, under normal glucose and, even more, under HG conditions; (c) cytosolic phospholipase A<sub>2</sub> activity and prostaglandin E2 release, stimulated by HG, were significantly reduced in P-ASCs co-cultured with HRECs; (d) HO-1 protein content was significantly higher in HG-P-ASCs/HRECs than P-ASCs/HRECs; and (e) VEGF-A levels in media from HG-co-cultures were reduced in P-ASCs/HRECs with respect to ASCs/HRECs. The data obtained highlighted the potential of autologous differentiated ASCs in future clinical applications based on cell therapy to counteract the damage induced by DR.https://www.mdpi.com/1422-0067/25/3/1774adipose mesenchymal stem cellspericyte-like differentiationhuman retinal endothelial cellsblood–retinal barrierdiabetic retinopathyhyperglycemia
spellingShingle Aleksandra Agafonova
Alessia Cosentino
Ivana Roberta Romano
Giovanni Giurdanella
Floriana D’Angeli
Rosario Giuffrida
Debora Lo Furno
Carmelina Daniela Anfuso
Giuliana Mannino
Gabriella Lupo
Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy
International Journal of Molecular Sciences
adipose mesenchymal stem cells
pericyte-like differentiation
human retinal endothelial cells
blood–retinal barrier
diabetic retinopathy
hyperglycemia
title Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy
title_full Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy
title_fullStr Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy
title_full_unstemmed Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy
title_short Molecular Mechanisms and Therapeutic Implications of Human Pericyte-like Adipose-Derived Mesenchymal Stem Cells in an In Vitro Model of Diabetic Retinopathy
title_sort molecular mechanisms and therapeutic implications of human pericyte like adipose derived mesenchymal stem cells in an in vitro model of diabetic retinopathy
topic adipose mesenchymal stem cells
pericyte-like differentiation
human retinal endothelial cells
blood–retinal barrier
diabetic retinopathy
hyperglycemia
url https://www.mdpi.com/1422-0067/25/3/1774
work_keys_str_mv AT aleksandraagafonova molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT alessiacosentino molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT ivanarobertaromano molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT giovannigiurdanella molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT florianadangeli molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT rosariogiuffrida molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT deboralofurno molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT carmelinadanielaanfuso molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT giulianamannino molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy
AT gabriellalupo molecularmechanismsandtherapeuticimplicationsofhumanpericytelikeadiposederivedmesenchymalstemcellsinaninvitromodelofdiabeticretinopathy